Venture Blick Signs Strategic MOU with Biodesigners to Boost Investment in Global Healthcare Start-ups
Seoul-based healthcare incubator Venture Blick, led by CEO Lee Hee-yeol, announced on the 10th that it has entered into a strategic Memorandum of Understanding (MOU) with Biodesigners, a company builder specializing in bio-enterprises. The MOU aims to facilitate investment attraction for start-ups in the global healthcare sector.
The signing ceremony, attended by key officials including Lee Hee-yeol, CEO of Venture Blick, Lee Dong-ho, co-CEO of Biodesigners, and Kim Myung-hwa, Vice President of Biodesigners, marked the beginning of a collaborative effort to foster growth in the venture investment ecosystem for healthcare start-ups.
Main areas of cooperation under the agreement:
Joint discovery and investment cooperation in the domestic healthcare start-up scene
Investment collaboration in foreign healthcare start-ups
Exchange of global insights on the healthcare market
With the aim of promptly identifying and nurturing promising companies, Lee Hee-yeol, CEO of Venture Blick, emphasized the importance of efficient evaluation processes. “We are committed to expanding our reach in the cold weather of the business landscape,” he stated.
Biodesigners’ co-CEO, Lee Dong-ho, expressed his agreement with Venture Blick’s approach in evaluating healthcare start-ups that cater to medical professionals and require both investment expertise and medical knowledge. He also highlighted the potential for collaboration in discovering foreign investment opportunities and attracting capital.
Specializing in the discovery, development, and investment of MedTech start-ups worldwide, Venture Blick operates on the foundation of the ‘VB Advisory Network’. This extensive global healthcare network spans across Korea, Singapore, Germany, India, and other countries.
Biodesigners, on the other hand, functions as a company builder that aids start-ups in the bio-enterprise sector by assuming the roles of designers and co-founders. Their comprehensive support encompasses technology incubation, talent acquisition, business strategy selection, and industrialization.
(From left in photo) Venture Blick Director Yeo In-seop and CEO Lee Hee-yeol and Biodesigners CEO Lee Dong-ho and Vice President Kim Myung-hwa / Photo = Venture Blick
VentureBlick (CEO Lee Hee-yeol) announced on the 10th that it has signed a strategic Memorandum of Understanding with the company Builder Biodesigners (Co-CEO Lee Dong-ho and Oh Seong-soo) to promote investment attraction on for start-ups in global healthcare.
The signing ceremony was attended by Lee Hee-yeol, CEO of VentureBlick, Lee Dong-ho, co-CEO of Biodesigners, Kim Myung-hwa, Vice President of Biodesigners, and key officials. The main contents of the agreement are △ joint discovery and investment cooperation in domestic healthcare startups △ investment cooperation in foreign healthcare start-ups △ exchange of global insight on the healthcare market.
This agreement was promoted with the intention of promoting the invigoration of the venture investment ecosystem specializing in healthcare. Lee Hee-yeol, CEO of VentureBlick, said, “In cold weather, it is important to quickly sort the boulders and discover promising companies. “We will expand,” he said.
Lee Dong-ho, co-CEO of Biodesigners, said, “I agree with VentureBrick’s approach to evaluating and vetting startups focused on medical professionals in the healthcare market, which requires investment expertise as well with medical expertise.” As such, we look forward to active cooperation in discovering foreign investment destinations and attracting investment.”
Venture Blick is a great healthcare incubator that systematically supports the discovery, development, and investment of MedTech startups around the world based on the ‘VB Advisory Network’, a large-scale global healthcare network in Korea, Singapore , Germany, and India. he has a corporation, etc.
Biodesigners are company builders who help start-ups to bio-enterprises, playing the role of ‘designers and co-founders’. We support all stages of bio-enterprises, from technology incubation to human resource selection, business direction selection, and industrialization.